The Effect of Non-invasive Auricular Acupoint Stimulation on Slow Transmission Constipation
NCT ID: NCT06680882
Last Updated: 2024-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE2
60 participants
INTERVENTIONAL
2024-11-07
2025-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods In a randomized clinical trial, 60 patients diagnosed with slow transit constipation (STC), ranging in age from 40 to 75 years, were allocated into two distinct cohorts: a study group and a control group. The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride, while the control group, also consisting of 30 patients, was administered prucapride as a monotherapy. To assess the efficacy of the interventions, various parameters were monitored, including serum levels of Neuropeptide Y (NPY), nitric oxide (NO), fecal water content, and gastrointestinal (GI) transit. The comparative therapeutic outcomes were determined by calculating symptom scores.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect Comparison of Electro-acupuncture and Prucalopride for Severe Chronic Constipation: a Randomized Controlled Trial
NCT02047045
Efficacy and Safety of Acupuncture for Functional Constipation
NCT01411501
Efficacy of Electroacupuncture Compared With Transcutaneous Electric Nerve Stimulation for Functional Constipation
NCT03391635
A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation
NCT00508482
Acupuncture for Chronic Constipation
NCT00746200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride
Auricular Acupoint Stimulation +prucapride
The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride
control group
also consisting of 30 patients, was administered prucapride as a monotherapy.
prucapride
was administered prucapride as a monotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Auricular Acupoint Stimulation +prucapride
The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride
prucapride
was administered prucapride as a monotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heng Deng
The Second hospital affiliated Anhui University of Chinese Medicine
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No. 2023AH050848
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
AH2022056
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.